Kane Biotech Inc. (TSXV: KNE)

Kane Biotech Revenue

Kane Biotech had revenue of 620.44K CAD in the quarter ending June 30, 2024, with 2,045.50% growth. This brings the company's revenue in the last twelve months to 757.11K, down -163.94% year-over-year. In the year 2023, Kane Biotech had annual revenue of 148.98K, down -4.95%.

• Revenue (ttm): 757.11K
• Revenue Growth: -163.94%
• P/S Ratio: 19.86
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 15.81M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	148.98K	-7.75K	-4.95%
Dec 31, 2022	156.73K	-1.45M	-90.25%
Dec 31, 2021	1.61M	266.20K	19.84%
Dec 31, 2020	1.34M	-351.95K	-20.78%
Dec 31, 2019	1.69M	1.19M	234.51%